herpes zoster neuralgia (medicine)
Conditions
Interventions
research group:Ultrasound-guided electroacupuncture stimulation of the spinal ganglia was performed on the basis of oral administration of conventional medications, with each electroacupuncture stimul
control subjects:Oral conventional medication: valacyclovir hydrochloride granules flushed, 300mg/dose twice daily for 2 weeks and then discontinued. Pregabalin capsules, administered according to the
Sponsors
The First People's Hospital of Fuyang District, Hangzhou
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1, Meet the diagnostic criteria for the acute phase of herpes zoster: patients with a recent (within one month) diagnosis of herpes zoster.2, The age limit is between 40 and 80 years old.3, Herpes is confined to the cervical, thoracic, or lumbar spinal innervation areas of the body on a single side of the body.4, The VAS score is >= 4 at the time of the initial visit.5, Have not been treated with immune-modulating medications or corticosteroids.6, Have not been subjected to minimally invasive interventional surgical procedures.7, The patient or his legal representative has signed an informed document consenting to participate in electroacupuncture therapy. , The patient or his/her legal representative had signed an informed document agreeing to participate in electroacupuncture therapy.
Exclusion criteria
Exclusion criteria: Patients with specific types of herpes zoster such as eye, ear, visceral, meningeal, generalized or rash-free.2 Women who are pregnant or breastfeeding.3 Individuals with a history of allergy to multiple medications.4 Patients with keloidal scarring.5 Patients with co-morbid severe systemic diseases or systemic failure including malignant tumors, psychiatric illnesses, connective tissue disorders, and hemophilia.6 Patients with a tendency to bleed or with known blood disorders.7 Patients with complex conditions that cannot be evaluated for safety.8 Patients who have a history of severe systemic diseases or generalized failure including malignancy, psychiatric disorders, connective tissue disease, and hemophilia. Patients with complex medical conditions that cannot be accurately assessed for therapeutic efficacy and safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale,VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| self-rating scale of sleep;Hamilton Anxiety Inventory score;Hamilton Depression Scale score;Quality of Life Assessment Scale score;Inflammatory factor (IL-6, TNF-a) indices before and after treatment;Incidence of PHN; | — |
Countries
China
Contacts
Public ContactXin Liu
The First People's Hospital of Fuyang District, Hangzhou
Outcome results
None listed